Posted by Michael Wonder on 27 Sep 2021
Access to and affordability of cancer medicines: time to focus on the last mile
21 September 2021 - In The Lancet Oncology, Adam Fundytus and colleagues present results from a global survey of oncologists on their perception of access to and availability of cancer medicines.
The primary objective of the study was to compare oncologists' perception of the top ten cancer medicines with the greatest public health benefit with the ones identified in the WHO Model List of Essential Medicines.
